|
GO_0016238
|
GO_0016238 |
|
|
kappa-type opioid receptor binding
|
GO_0031851 |
[Binding to a kappa-type opioid receptor.] |
|
opioid receptor binding
|
GO_0031628 |
[Binding to an opioid receptor.] |
|
delta-type opioid receptor binding
|
GO_0031850 |
[Binding to a delta-type opioid receptor.] |
|
aggresome
|
GO_0016235 |
[An inclusion body formed by dynein-dependent retrograde transport of an aggregated protein on microtubules.] |
|
telomere capping
|
GO_0016233 |
[A process in which telomeres are protected from degradation and fusion, thereby ensuring chromosome stability by protecting the ends from both degradation and from being recognized as damaged DNA. May be mediated by specific single- or double-stranded telomeric DNA binding proteins.] |
|
HNK-1 sulfotransferase activity
|
GO_0016232 |
[Catalysis of the synthesis of the HKK-1 carbohydrate epitope; adds a sulfate group to a precursor, GlcA-beta-(1->3)-Gal-beta-(1->4)-GlcNAc-beta-(1->R), forming sulfo-3GlcA-beta-(1->3)-Gal-beta-(1->4)-GlcNAc-beta-(1->R).] |
|
beta-N-acetylglucosaminidase activity
|
GO_0016231 |
[Catalysis of the hydrolysis of terminal non-reducing N-acetyl-D-glucosamine residues in N-acetyl-beta-D-glucosaminides.] |
|
sphingomyelin phosphodiesterase activator activity
|
GO_0016230 |
[Binds to and increases the activity of the enzyme sphingomyelin phosphodiesterase.] |
|
nociceptin receptor binding
|
GO_0031853 |
[Binding to a nociceptin receptor.] |
|
mu-type opioid receptor binding
|
GO_0031852 |
[Binding to a mu-type opioid receptor.] |
|
oxytocin receptor binding
|
GO_0031855 |
[Binding to an oxytocin receptor.] |
|
orexigenic neuropeptide QRFP receptor binding
|
GO_0031854 |
[Binding to an orexigenic neuropeptide QRFP receptor.] |
|
type 1 parathyroid hormone receptor binding
|
GO_0031857 |
[Binding to a type 1 parathyroid hormone receptor.] |
|
parathyroid hormone receptor binding
|
GO_0031856 |
[Binding to a parathyroid hormone receptor.] |
|
platelet activating factor receptor binding
|
GO_0031859 |
[Binding to a platelet activating factor receptor.] |
|
pituitary adenylate cyclase-activating polypeptide receptor binding
|
GO_0031858 |
[Binding to a pituitary adenylate cyclase-activating polypeptide receptor.] |
|
phytosteroid biosynthetic process
|
GO_0016129 |
[The chemical reactions and pathways resulting in the formation of phytosteroids, steroids that differ from animal steroids in having substitutions at C24 and/or a double bond at C22. Phytosteroids are so named because they occur in higher plants; some, notably ergosterol, are also found in fungi.] |
|
phytosteroid metabolic process
|
GO_0016128 |
[The chemical reactions and pathways involving phytosteroids, steroids of higher plants that differ from animal steroids in having substitutions at C24 and/or a double bond at C22. Phytosteroids are so named because they occur in higher plants; some, notably ergosterol, are also found in fungi.] |
|
fMet-Leu-Phe receptor binding
|
GO_0031761 |
[Binding to a fMet-Leu-Phe receptor.] |